Infosys Completes Acquisition of Product Design and Development Firm, Kaleidoscope Innovation

Infosys

PR86058

 

BENGALURU, India and CINCINNATI, Ohio, Oct. 12, 2020 /PRNewswire=KYODO JBN/--

 

    Infosys[https://www.infosys.com/] (NYSE: INFY), a global leader in

next-generation digital services and consulting, today announced that it has

completed the acquisition of Kaleidoscope Innovation[https://kascope.com/], a

full-spectrum product design, development and insights firm innovating across

medical, consumer and industrial markets, bolstering capabilities in the design

of smart products. This follows the

announcement[https://www.infosys.com/newsroom/press-releases/2020/acquire-product-design-development-firm.html#:~:text=Infosys%20(NYSE%3A%20INFY)%2C,markets%2C%20bolstering%20capabilities%20in%20the ] the company made on September 03, 2020.

 

    This acquisition demonstrates Infosys' commitment to innovate for its

clients, and make meaningful impact on human lives through a combination of

cutting-edge technologies. This collaboration further aims to revolutionize

patient care, treatment, diagnostics and consumer health, across the world.

 

    With Kaleidoscope Innovation, Infosys will further strengthen its digital

offerings and also its workforce, with a diverse talent pool with extensive

knowledge of design and engineering. Kaleidoscope leverages a deep

understanding of clinical environments, strong product development capabilities

across domains, and a consultancy-style approach addressing human factors,

product design, UI/UX design, research & insight, development and

visualization. It serves a marquee and diversified customer base with state of

the art, in-house labs, 3D design environments and customer experience centers.

 

    Kaleidoscope Innovation designs microsurgical instruments, devices used in

minimally invasive surgery, drug delivery devices for ophthalmic therapies and

user-centric wearables. It also offers usability testing in support of

regulatory submissions, including the delivery mechanism for aortic stents.

 

    Infosys is excited to welcome Kaleidoscope Innovation and its leadership

team.

 

    About Kaleidoscope Innovation

 

    Kaleidoscope Innovation is a full-service product development firm

innovating across medical, consumer and industrial markets. For over 30 years,

clients have partnered with Kaleidoscope to improve the human experience.

Kaleidoscope offers both consultancy-style and onsite services, across a full

breadth of disciplines to meet their client's needs where needed, including

insights & human factors, medical affairs, industrial design & user experience,

engineering, visualization and software development. For more information about

Kaleidoscope Innovation, please visit www.kascope.com

 

    About Infosys

 

    Infosys is a global leader in next-generation digital services and

consulting. We enable clients in 46 countries to navigate their digital

transformation. With nearly four decades of experience in managing the systems

and workings of global enterprises, we expertly steer our clients through their

digital journey. We do it by enabling the enterprise with an AI-powered core

that helps prioritize the execution of change. We also empower the business

with agile digital at scale to deliver unprecedented levels of performance and

customer delight. Our always-on learning agenda drives their continuous

improvement through building and transferring digital skills, expertise, and

ideas from our innovation ecosystem.

 

    Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your

enterprise navigate your next.

 

    Safe Harbor

 

    Certain statements in this release concerning our future growth prospects,

financial expectations and plans for navigating the COVID-19 impact on our

employees, clients and stakeholders are forward-looking statements intended to

qualify for the 'safe harbor' under the Private Securities Litigation Reform

Act of 1995, which involve a number of risks and uncertainties that could cause

actual results to differ materially from those in such forward-looking

statements. The risks and uncertainties relating to these statements include,

but are not limited to, risks and uncertainties regarding COVID-19 and the

effects of government and other measures seeking to contain its spread, risks

related to an economic downturn or recession in India, the United States and

other countries around the world, changes in political, business, and economic

conditions, fluctuations in earnings, fluctuations in foreign exchange rates,

our ability to manage growth, intense competition in IT services including

those factors which may affect our cost advantage, wage increases in India, our

ability to attract and retain highly skilled professionals, time and cost

overruns on fixed-price, fixed-time frame contracts, client concentration,

restrictions on immigration, industry segment concentration, our ability to

manage our international operations, reduced demand for technology in our key

focus areas, disruptions in telecommunication networks or system failures, our

ability to successfully complete and integrate potential acquisitions,

liability for damages on our service contracts, the success of the companies in

which Infosys has made strategic investments, withdrawal or expiration of

governmental fiscal incentives, political instability and regional conflicts,

legal restrictions on raising capital or acquiring companies outside India,

unauthorized use of our intellectual property and general economic conditions

affecting our industry and the outcome of pending litigation and government

investigation. Additional risks that could affect our future operating results

are more fully described in our United States Securities and Exchange

Commission filings including our Annual Report on Form 20-F for the fiscal year

ended March 31, 2020. These filings are available at www.sec.gov. Infosys may,

from time to time, make additional written and oral forward-looking statements,

including statements contained in the Company's filings with the Securities and

Exchange Commission and our reports to shareholders. The Company does not

undertake to update any forward-looking statements that may be made from time

to time by or on behalf of the Company unless it is required by law.

 

 

    Logo: https://mma.prnewswire.com/media/633365/Infosys_Logo.jpg

    Caption: Infosys Logo

 

    Source: Infosys

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中